Stock Yards Bancorp reported record third quarter earnings of $43.5 million, or $1.40 per diluted share, driven by net interest margin expansion, strong credit quality, and record non-interest income. The results reflect positive loan growth, the full quarter impact of the Field & Main Bancorp merger, and increased revenue from wealth management, treasury fees, and brokerage. Despite some deposit contraction and elevated loan payoffs, the company remains well-capitalized and plans to manage assets below $10 billion by year-end ahead of regulatory changes in 2027. The merger integration is progressing well, positioning the bank for long-term growth in new markets.
Stock Yards Bancorp's record third quarter earnings provide context for financial sector performance. For readers following the financial sector, here is Pluang's market snapshot as of Oct 28, 2026 18:22 WIB: out of 142 priced US financial stocks, 64 rose and 69 fell. Notable movers include Marsh & McLennan Companies, Inc. (MRSH) at USD 195.09 with a 2.32% increase, KB Financial Group, Inc. (KB) at USD 115.08 up 2.29%, and Barclays PLC (BCS) at USD 22.96 rising 2.23%.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
